Modafinil: mischaracterization.
Kruszewski
Stefan P
SP
Klotz
Steven G
SG
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D001559:Benzhydryl Compounds / Q000009:adverse effects / Q000494:pharmacology*; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000494:pharmacology*; D004345:Drug Industry; D004348:Drug Labeling; D006801:Humans; D000077408:Modafinil; D019966:Substance-Related Disorders; D014481:United States; D014486:United States Food and Drug Administration
D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D000077408:Modafinil